OpenVSafe by OpenVAERS
Search V-safe

G26-42434-19909

2 vaccinations 16 coded responses 24 check-ins 16 free-text entries 0 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
403 / KY
Registered
2020-12-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Registered in v-safe
  2. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness
    Free text: Swollen lymph nodes in neck on side of injextion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Swelling
    Free text: Swollen and tender cervical lymph nodes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Cervical lymph node swelling and tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Improving lymphadenopathy in neck.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Mild no tender cervical lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2020-12-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-23
    Survey response — day 7, dose 1
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2020-12-30
    Survey response — day 14, dose 1
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical lymphadenopathy. Has not changed in size or tenderness since the vaccination.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-06
    Survey response — day 0, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical lymphadenopathy since day of first vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Persistent cervical nodes since first shot.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Persistent cervical nodes on the left from first vaccine and large tender nodes in the right axillary area as well as cervical area on the right since last night.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Continued lymphadenopathy bilateral cervical and right axillary nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical and axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical and axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical and axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-01-15
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Persistent cervical lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-03
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-07
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-01-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-06Pfizer-BioNTech

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-17

Systemic reaction (other): Swollen lymph nodes in neck on side of injextion

2020-12-18

Systemic reaction (other): Swollen and tender cervical lymph nodes.

2020-12-19

Systemic reaction (other): Cervical lymph node swelling and tenderness

2020-12-20

Systemic reaction (other): Improving lymphadenopathy in neck.

2020-12-21

Systemic reaction (other): Mild no tender cervical lymphadenopathy

2020-12-22

Systemic reaction (other): Persistent cervical lymphadenopathy

Release 1 — day 7, dose 1

2020-12-23

Systemic reaction (other): Persistent cervical lymphadenopathy

Release 1 — day 14, dose 1

2020-12-30

Symptoms: Persistent cervical lymphadenopathy. Has not changed in size or tenderness since the vaccination.

Release 1 — day 0, dose 2

2021-01-06

Systemic reaction (other): Persistent cervical lymphadenopathy since day of first vaccine

Release 1 — days 1–6 daily, dose 2

2021-01-07

Systemic reaction (other): Persistent cervical nodes since first shot.

2021-01-08

Systemic reaction (other): Persistent cervical nodes on the left from first vaccine and large tender nodes in the right axillary area as well as cervical area on the right since last night.

2021-01-09

Systemic reaction (other): Continued lymphadenopathy bilateral cervical and right axillary nodes

2021-01-10

Systemic reaction (other): Persistent cervical and axillary lymphadenopathy

2021-01-11

Systemic reaction (other): Persistent cervical and axillary lymphadenopathy

2021-01-12

Systemic reaction (other): Persistent cervical and axillary lymphadenopathy

Release 2 — day 7, dose 2

2021-01-15

Systemic reaction (other): Persistent cervical lymphadenopathy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDLymph node pain ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROTenderness ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release